Hikma Pharmaceuticals【HIK】銘柄情報

Hikma Pharmaceuticals Plc (HIK) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1,451.00

( -0.75% )

買値

1,456.00

売値

1,457.00

出来高

648,778

1,445.00 日の範囲 1,461.00

1,187.00 52 週間の範囲 2,086.00

時価総額

3.091B

前日終値

1,462.00

始値

1,460.00

時刻

217

1451

(O)

最終取引時間

財務取引量

9,422,789p

VWAP

1,452.3903

平均取引量 (3 か月)

1,046,449p

発行済株式数

213,030,512

配当利回り

0.84

PER

10.98

1 株当たり利益 (EPS)

1.81

歳入

3.35B

純利益

402M

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primari... Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.hikma.com

本社

London, United Kingdom

設立

1978

Hikma Pharmaceuticals Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,462p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,187.00p to 2,086.00p.

Hikma Pharmaceuticals currently has 213,030,512 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £3.09 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 10.98.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-11	-0.752393980848	1462	1500	1445	513622	1469.4012501	DE
4	-27	-1.82679296346	1478	1503	1397	835412	1456.16606685	DE
12	176	13.8039215686	1275	1503	1236	889353	1385.12348895	DE
26	-63	-4.16116248349	1514	1691	1187	1121446	1388.51256943	DE
52	-635	-30.4410354746	2086	2086	1187	879514	1524.80514081	DE
156	-476	-24.7016087182	1927	2360	1187	609463	1757.88550339	DE
260	-998	-40.7513270723	2449	2703	1174.5	602981	1774.10157358	DE